Abcely is a seed startup based in France. 2 investors tracked.
Abcely is a company headquartered in France. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Abcely is a biotech company focused on developing innovative medical and pharmaceutical technologies for the treatment of mucosal cancers, offering patients who have reached a therapeutic impasse a new solution based on a novel concept in cancer immunotherapy involving orally active immunoglobulin-based therapeutic agents.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.